Skip to main content

Table 3 Comparison between PIs of the local and imported products by word counting of 20 criteria

From: Comparative analysis of package inserts of local and imported antihypertensive medications in Palestine

Variable

Local

Imported

P valuea

Fold difference in medians

Median [Q1-Q3]

Median [Q1-Q3]

Inactive ingredients (excipients)

0.00 [0.00–0.00]

33.50 [20.00–58.50]

0.000

>33.50

Therapeutic class

0.00 [0.00–4.00]

5 [3.5–9.00]

0.016

>5.00

Indications

14.00 [10.00–20.00]

25.00 [18.50–37.00]

0.023

1.78

Drug dose

0.00 [0.00–0.00]

0.00 [0.00–108.5]

0.401

Missing dose

30.00 [15.00–34.70]

30.00 [26.00–34.50]

0.797

1.00

Maximum dose

0.00 [0.00–0.00]

0.00 [0.00–0.00]

0.898

Directions for use

37.00 [20.00–43.00]

33.00 [24.00–71.00]

0.365

1.12

Overdose and management

45.70 [38.00–71.00]

62.50 [44.00–80.00]

0.365

1.37

Warning and precautions

49.00 [36.00–173.00]

161.50 [117.50–322.00]

0.010

2.29

Effect on ability to drive and use machines

0.00 [0.00–20.50]

42.00 [33.00–47.00]

0.002

>42.00

Contraindications

28.33 [9.00–60.50]

89.00 [66.00–126.5]

0.000

3.14

Adverse drug reactions

66.00 [62.00–97.00]

334.00 [235.50–448.50]

0.000

5.06

Drug-drug interactions

57.70 [49.00–73.00]

151.00 [109.00–304.00]

0.001

2.62

Drug-food interactions

0.00 [0.00–13.00]

23.00 [12.00–35.00]

0.001

>23.00

Pregnancy considerations

16.70 [12.00–25.00]

25.00 [20.00–71.00]

0.010

1.50

Lactation considerations

13.00 [8.00–15.70]

16.00 [9.00–21.50]

0.116

1.23

Pediatric considerations

13.00 [6.70–55.00]

62.00 [39.50–72.50]

0.019

4.77

Possibility of tablet splitting

0.00 [0.00–0.00]

7.00 [4.50–12.00]

0.000

>7.00

Possibility of crushing and mixing with food or beverages

5.00 [1.50–5.00]

5.00 [3.00–7.00]

0.270

1.00

Storage

22.00 [15.00–35.00]

55.50 [47.50–59.00]

0.000

2.52

  1. aThe p-values are bold where they are less than the significance level cut-off of 0.05